Isabel Sola

14PUBLICATIONS
56CO-AUTHORS
Genome structure and regulationSequence analysisMedical infection agents (incl. prions)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 24, 2025
SARS-CoV-2-derived RNA replicons as safe and effective vaccines.

Marta Villarejo-Torres, Iván Nombela-Diaz, Diego Muñóz-Santos

|Apr 24, 2025
SARS-CoV-2 biological clones are genetically heterogeneous and include clade-discordant residues.

Ana Isabel de Ávila, María Eugenia Soria, Brenda Martínez-González

|Aug 29, 2024
Interaction between SARS-CoV PBM and Cellular PDZ Domains Leading to Virus Virulence.

Jose M Honrubia, Jose R Valverde, Diego Muñoz-Santos

|Feb 28, 2023
Engineering potent live attenuated coronavirus vaccines by targeted inactivation of the immune evasive viral deubiquitinase.

Sebenzile K Myeni, Peter J Bredenbeek, Robert C M Knaap

|Nov 11, 2022
Pulsed-Xenon Ultraviolet Light Highly Inactivates Human Coronaviruses on Solid Surfaces, Particularly SARS-CoV-2.

Melissa Bello-Perez, Iris Esparza, Arancha De la Encina

|Sep 21, 2022
MERS-CoV ORF4b is a virulence factor involved in the inflammatory pathology induced in the lungs of mice.

Melissa Bello-Perez, Jesús Hurtado-Tamayo, Ricardo Requena-Platek

Pageof 3